Trials / Sponsors / Apogenix GmbH
Apogenix GmbH
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease COVID-19 | Phase 3 | 2022-11-03 |
| Completed | APG101 in Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 1 | 2013-01-01 |
| Completed | APG101 in Glioblastoma Glioblastoma Multiforme | Phase 2 | 2009-12-01 |